Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax Journal Articles Refereed uri icon

Overview

Published in

  • Blood

Time

Date/time value

  • 2017

Identity

Digital Object Identifier (DOI)

  • 10.1182/blood-2017-01-763003

Additional Document Info

Parent Title

  • BLOOD

Volume

  • 129

Issue

  • 25

Publisher

  • American Society of Hematology